Javascript must be enabled to continue!
Prevalence of drooling in patients with parkinson disease
View through CrossRef
Background and aims: Drooling is the involuntary spillage of saliva from the mouth and is apparent in approximately 75% of individuals with PD and was historically interpreted as resulting from hypersecretion of saliva because of autonomic dysfunction. Alteration in salivary gland function is believed to arise from PD-associated changes in the autonomic nervous system and possibly involves the salivary para-sympathetic ganglia. Irrespective of the amount of saliva produced, drooling probably occurs because of PD-related inability to efficiently swallow with normal frequency, an inability to fully close the mouth, and an anterior flexed head position. Recognizing and managing sialorrhea is an important issue to ensure quality of life for patients with PD. The study aims to identify prevalence of drooling at patients hospitalized at neurology department in Tirana and increasing awareness about the importance of sialorrhea treatment in PD patients. Methods: In this retrospective study we investigated the prevalence of drooling in PD patients. We investigated the distribution of drooling according to sex and age and also the impact of drooling in this population by neurological examination and questionnaires given to them in a 6-month time distance. In addition, we studied the impact of gender in drooling in this population. Results: Our results show that most of the patients participating in the study showed signs of drooling. A significant correlation exists between drooling and stages of disease. Furthermore, in males, the correlation between the prevalence of drooling was found to be clinically significant compared to females. Conclusion: Our findings suggest that drooling is a major concern in the course of PD and should be addressed and treated early in patients with PD. Key word: Parkinson Disease, prevalence, sialorrhea, quality of life
European University of Tirana
Title: Prevalence of drooling in patients with parkinson disease
Description:
Background and aims: Drooling is the involuntary spillage of saliva from the mouth and is apparent in approximately 75% of individuals with PD and was historically interpreted as resulting from hypersecretion of saliva because of autonomic dysfunction.
Alteration in salivary gland function is believed to arise from PD-associated changes in the autonomic nervous system and possibly involves the salivary para-sympathetic ganglia.
Irrespective of the amount of saliva produced, drooling probably occurs because of PD-related inability to efficiently swallow with normal frequency, an inability to fully close the mouth, and an anterior flexed head position.
Recognizing and managing sialorrhea is an important issue to ensure quality of life for patients with PD.
The study aims to identify prevalence of drooling at patients hospitalized at neurology department in Tirana and increasing awareness about the importance of sialorrhea treatment in PD patients.
Methods: In this retrospective study we investigated the prevalence of drooling in PD patients.
We investigated the distribution of drooling according to sex and age and also the impact of drooling in this population by neurological examination and questionnaires given to them in a 6-month time distance.
In addition, we studied the impact of gender in drooling in this population.
Results: Our results show that most of the patients participating in the study showed signs of drooling.
A significant correlation exists between drooling and stages of disease.
Furthermore, in males, the correlation between the prevalence of drooling was found to be clinically significant compared to females.
Conclusion: Our findings suggest that drooling is a major concern in the course of PD and should be addressed and treated early in patients with PD.
Key word: Parkinson Disease, prevalence, sialorrhea, quality of life.
Related Results
Impact of Cognitive Dysfunction on Drooling in Parkinson's Disease
Impact of Cognitive Dysfunction on Drooling in Parkinson's Disease
<b><i>Background:</i></b> Parkinson's disease (PD) is commonly characterized<b> </b>by its motor symptoms such as resting tremor, rigidity, brad...
Drooling may be Associated with Dysphagia Symptoms in Multiple Sclerosis
Drooling may be Associated with Dysphagia Symptoms in Multiple Sclerosis
AbstractDuring the process of the multiple sclerosis (MS), persons with multiple sclerosis (PwMS) may experience drooling (sialorrhea) issues that are frequently disregarded. The e...
Drooling and Dental Caries in Children with Cerebral Palsy - Is There Any Link?
Drooling and Dental Caries in Children with Cerebral Palsy - Is There Any Link?
Background Drooling is commonly witnessed in children with cerebral palsy CP and can be distressing not only for the affected children but also for their parents andor caregivers. ...
Modafinil for Drooling in Cerebral Palsy
Modafinil for Drooling in Cerebral Palsy
Two patients with spastic cerebral palsy recently treated with modafinil at the Walter Reed Army Medical Center child neurology clinic have stopped drooling. This occurred after st...
Pemakain Lip Bumper pada Anak Cerebral Palsi dengan Kasus Drooling, Inkompetensi Bibir dan Kebiasaan Menggigit-gigit Bibir Bawah
Pemakain Lip Bumper pada Anak Cerebral Palsi dengan Kasus Drooling, Inkompetensi Bibir dan Kebiasaan Menggigit-gigit Bibir Bawah
Latar Belakang. Anak yang menderita cerebral palsi pada umumnya mempunyai keluhan ketidakmampuan dalam pengontrolan saliva dalam rongga mulutnya. Pada kondisi tersebut penderita me...
Awareness and Use of Different Techniques among Speech and Language Pathologists for Controlling Drooling in Children with Cerebral Palsy
Awareness and Use of Different Techniques among Speech and Language Pathologists for Controlling Drooling in Children with Cerebral Palsy
Background: Drooling is a prevalent and socially distressing condition affecting 25–35% of children with cerebral palsy (CP), with approximately 10% experiencing severe sialorrhea....
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...

